Summit Therapeutics Inc.

Q3 2022 13F Holders

Symbol
SMMT
CUSIP
86627T108
Type
Equity
Class
COM
Num filings
46
Total reported value, excl. options
$3.78 M
Manager Report Date Value ($000) Shares Option Type